
Stryker faces investigation after CEO reveals ongoing manufacturing issues, stock drops nearly 9%.
Stryker Corp. is under investigation by Pomerantz LLP following the CEO's announcement that a manufacturing problem affecting its peripheral vascular inventory, initially expected to be resolved in Q3 2026, will now continue into Q4. This revelation ...

